CAROLINE POPPER

Profile

First Name

: CAROLINE

Middle Name

:

Last Name

: POPPER

Related Companies
Titles
Company Name
Related People
DIRECTOR
CLAROS DIAGNOSTICS INC
JEFFREY T BARNES, JOHN P. DAVIS, MARC GOLDBERG, MICHAEL MAGLIOCHETTI, DAVID STEINMILLER
EXECUTIVE OFFICER, DIRECTOR
INNOVATIVE BIOSENSORS INC
WILLIAM BROOKE, WILLIAM W. BROOKE, JOHN DE KONING, JOSEPH DEL GUERCIO, RIGG W. MOHLER, TED OLSEN, CAROLINE POPPER, M.D., M.P.H., COLE S. VAN NICE, DAVID YOST, DAVID A. YOST, PH.D.
DIRECTOR
NANOMR, INC.
GAVIN CHRISTENSEN, SALLY CORNING, LISA DUNLEA, VICTOR ESCH, VICTOR C. ESCH, STEVE C, GULLANS, STEVE C. GULLANS, STEVEN GULLANS, AUGUSTINE LAWLOR, WANETA C. TUTTLE
DIRECTOR
RAPID PATHOGEN SCREENING INC
DOUGLAS W. BERG, STEPHEN R. LA NEVE, JULES MUSINGER, THOMAS ORSINI, WILLIAM RUECKERT, WILLIAM D. RUECKERT, HANJOON RYU, CHARLES T. SALDARINI, DANIEL SAMBURSKY, JOSE SAMBURSKY, ROBERT SAMBURSKY, MICHAEL STRAUSS, ROBERT VANDINE, J. SCOTT WOMBLE
DIRECTOR
RPS DIAGNOSTICS, INC.
PETER V. GRADY, STEPHEN R. LA NEVE, CHRISTOPHER A. MICHAELS, JULES MUSINGER, CHARLES T. SALDARINI, DANIEL L. SAMBURSKY, ROBERT P. SAMBURSKY, ROBERT W. VANDINE
DIRECTOR
20/20 GENESYSTEMS, INC.
JONATHAN COHEN, RICHARD M. COHEN, JOHN G COMPTON, DEAN HAUTAMAKI, MICHAEL HERTZBERG, JOEL KANTER, VLADIMIR KNEZEVIC, WEI LU, PRASANTH REDDY, JOHN W. ROLLINS, MICHAEL A ROSS, ANNE SHIFLETT, LARRY SHULMAN, DONALD WALLACH, JIMINY ZHOU
DIRECTOR
BALX HOLDINGS, LLC
DAVID BELLUCK, PHILIP BORDEN, KURT BRYKMAN, JAMES A. DATIN, JEREMY GOLDBERG, MICHAEL J. LEHMANN, TODD LYNCH, MIKE MAGLIOCHETTI, MAX OSOFSKY, AFSHIN SAFAVI, CRAIG STERN
DIRECTOR
SIDX, INC.
JILL JOHNSEN, ERIC LARSEN, DAN RATNER, DANIEL RATNER, BRYAN WHITE
EXECUTIVE OFFICER, DIRECTOR
INFINITY BIO, INC.
BILL CAMPBELL, MALEK FAHEM, MATTHEW HELLAUER, BENJAMIN LARMAN, H. BENJAMIN LARMAN, JOY NASSIF, JOY M NASSIF, HERMAN SCHOLTZ
EXECUTIVE OFFICER
PANGIA BIOTECH, INC.
JOSEPH FRATTAROLI, GARTH LEES-ROLFE, HOLLY MAGLIOCHETTI, OBDULIO PILOTO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-11
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Debt 
2026-04-08 
2025-08-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-13 
2025-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-18 
2024-06-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
2023-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
2021-10-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-09-24 
2016-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-11 
2016-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-19 
2016-02-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-31 
2016-02-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-28 
2015-12-07
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-03 
2014-12-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-03 
2013-12-20
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2013-12-17 
2013-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-17 
2013-07-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-08 
2013-07-09
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2013-06-26 
2012-10-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-08 
2011-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-08 
2010-11-10
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-10-29 
2009-09-08
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2009-08-14 
2009-03-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-18